Shiying Yu

Challenges to effective cancer control in China, India, and Russia

Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky et al. · The Lancet Oncology · 2014 · 497 citations

Medicine, Global Health, Cancer Management +9

Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study

Fei Ma, Quchang Ouyang, Wěi Li et al. · Journal of Clinical Oncology · 2019 · 335 citations

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

Ann‐Lii Cheng, Zhongzhen Guan, Zhendong Chen et al. · European Journal of Cancer · 2012 · 261 citations · Full text

Baseline Status, Hepatology, Medicine +10

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

Lin Shen, Jin Li, Jianming Xu et al. · Gastric Cancer · 2014 · 241 citations · Full text

Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study

Qing Zhou, Chong‐Rui Xu, Ying Cheng et al. · Cancer Cell · 2021 · 220 citations

Advanced Nsclc, Novel Therapy, Multicenter Phase 3 +9